Industry
From U.S. (Toll Free) : +16467917070    |   UK : +442030260021     |    sales@businessmarketinsights.com

South America Dermatology OTC Medications Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type (Tablets and Capsules, Gels, Creams and Ointments, and Others), Route of Administration (Topical and Oral), Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts, and Others), and Distribution Channel (Online Distribution and Offline Distribution)      

Report Code :  BMIRE00025066
No. of Pages :  178
Published Month :  Jun 2022
Category :  Life Sciences
$299 per month

Best Plan
  • All Reports in One Industry
  • All Reports Read Access
  • Subscription Duration : 12 Months
  • Monthly New Reports Added
  • $1200 Yearly Saving

The SAM dermatology OTC medications market is expected to grow from US$ 935.31 million in 2021 to US$ 1,181.05 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2021 to 2028.

One of the dermatology OTC medications market's most visible trends is the shift of manufacturers from prescription pharmaceuticals toward over-the-counter products. Many manufacturers are shifting their products from Rx (prescription) to OTC. In its 2019 annual report, Bayer AG declared it would convert some of its prescriptive medications suitable for self-care to OTC as part of its strategy. This strategy is expected to increase the availability of OTC medications for a variety of illnesses in developing and developed countries. Rx-to-OTC is a feasible and enticing alternative for organizations seeking a life cycle extension strategy, enabling consumers to take control of their health. Transitioning to an OTC model may assist in maintaining target revenue and increasing a product's lifetime value. Furthermore, organizations with pharmaceutical and consumer health sections can readily implement the Rx-to-OTC approach. Moreover, Rx-to-OTC conversions offer significant benefits to patients, retailers, and manufacturers. Patients like the unique benefits of OTC drugs, such as lower costs and the opportunity to make treatment decisions without the involvement of doctors or insurers. Retailers gain from having more selections on their shelves, especially if the product is well known. Furthermore, research has revealed that OTC medication products can save healthcare systems billions of dollars. As people spend more money on OTC products than on prescription drugs, there will be a tremendous need for OTC products in the future years, thereby driving the SAM market growth.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM dermatology OTC medications market. The SAM dermatology OTC medications market is expected to grow at a good CAGR during the forecast period. 

 

SAM Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    


SAM Dermatology OTC Medications Market Segmentation           

 

The SAM dermatology OTC medications market is segmented based on product type, route of administration, indication, distribution channel, and country. Based on product type, the market is segmented into tablets and capsules, gels, creams and ointments, and others. The creams and ointments segment dominated the market in 2020; however, the tablets and capsules segment is expected to be the fastest growing segment during the forecast period. Based on route of administration, the market is segmented into topical and oral. The topical segment dominated the market in 2020; however, oral segment is expected to be a faster growing segment during the forecast period. Based on indication, the market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment dominated the market in 2020 and is expected to be the fastest growing segment during the forecast period. The dermatitis segment is further classified into atopic dermatitis, contact dermatitis, and others. The acne segment is further segmented into non-inflammatory acne and inflammatory acne. The psoriasis segment is further segmented into plaque psoriasis, guttate psoriasis, and others. The fungal disease is further segmented into athlete's foot, ringworm, fungal nail infections, and others. Moreover, the warts segment is further segmented into common warts, flat warts, and others. Based on distribution channel, the market is segmented into online distribution and offline distribution. The offline distribution segment dominated the market in 2020 and online distribution segment is expected to be a faster growing segment during the forecast period. The offline distribution is further segmented into retail and hospital pharmacies and super and hypermarkets. Based on country, the market is segmented into Brazil, Argentina, and the rest of SAM.         

 

Bausch Health Companies Inc.; Bayer AG; Dr. Reddy's Laboratories; Galderma; GlaxoSmithKline plc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; Perrigo Company plc; and Viatris Inc. are among the leading companies in the SAM dermatology OTC medications market.

  1. Bausch Health Companies Inc.
  2. Bayer AG  
  3. Dr. Reddy's Laboratories
  4. Galderma
  5. GlaxoSmithKline plc.
  6. Johnson and Johnson Services, Inc.
  7. LEO Pharma A/S       
  8. Perrigo Company plc
  9. Viatris Inc.  
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM dermatology OTC medications market.           
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the SAM dermatology OTC medications market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the dermatology OTC medications market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  


Contact Us : +442081254005 | Email : sales@businessmarketinsights.com
© Copyright 2025 - Business Market Insights. All rights reserved